CD58 and neoplasm: A genome-wide CRISPR library screening conducted in a coculture model involving the acute lymphoblastic leukemia cell line Nalm6 and CD19 CAR T cells revealed that CD58 loss in tumor cells affects optimal IS formation with CAR T cells, resulting in impaired CAR T-cell responses110.